Atlas Venture Associates XII, L.P.'s Net Worth
$0
Estimate Recalculated Nov 7, 2024 11:54AM EST
Who is Atlas Venture Associates XII, L.P.?
Atlas Venture Associates XII, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Vigil Neuroscience, Inc., Aerovate Therapeutics, Inc., and Gemini Therapeutics, Inc. /DE.
SEC CIK
Atlas Venture Associates XII, L.P.'s CIK is 0001845875
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Gemini Therapeutics, Inc. /DE (IRON) Snapshot price: $50.35
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Vigil Neuroscience, Inc. (VIGL) Snapshot price: $3.53
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +304.67% | 4.39M |
$14.00 |
—
| 5.84M |
Jan 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Aerovate Therapeutics, Inc. (AVTE) Snapshot price: $1.9
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.1M |
$14.00 |
—
| 3.1M |
Jul 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |